PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 41.00
+1.20 (3.02%)
At close: Mar 6, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 5.64 billion as of March 6, 2026. Its market cap has increased by 36.53% in one year.
Market Cap
5.64B
Enterprise Value
5.51B
Revenue
667.47M
Ranking
n/a
PE Ratio
160.29
Stock Price
41.00
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 5.64B, an increase of 43.19%. That is a compound annual growth rate of 11.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.64B | 37.26% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 5.98B |
| Shanghai OPM Biosciences | 5.93B |
| Novogene | 5.66B |
| Kexing Biopharm | 5.63B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.55B |
| Wuhan Hvsen Biotechnology | 5.12B |
| Hangzhou Biotest Biotech | 5.10B |
| Beijing Bohui Innovation Biotechnology Group | 4.93B |